Amylyx Pharmaceuticals Inc (AMLX) — Defensive Interval Ratio
Amylyx Pharmaceuticals Inc (AMLX) has a Defensive Interval Ratio of 1158 days as of March 2026. Defensive assets of $50.63 Million (cash $-, short-term investments $50.63 Million, receivables $-) cover 1158 days of daily cash needs of $43.74K/day. See Amylyx Pharmaceuticals Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Amylyx Pharmaceuticals Inc Defensive Interval Ratio (2020–2025)
This chart shows how Amylyx Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the ratio stands at 1158 days, meaning defensive assets of $50.63 Million can fund 1158 days of operations without new revenue. See Amylyx Pharmaceuticals Inc balance sheet quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Amylyx Pharmaceuticals Inc (2020–2025)
The table below presents the year-by-year Defensive Interval Ratio for Amylyx Pharmaceuticals Inc from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see AMLX stock market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1455 days | $90.42 Million | $62.16K/day | $- | $90.33 Million | ▲ +175 days |
| 2024 | 1279 days | $99.56 Million | $77.82K/day | $- | $99.11 Million | ▲ +206 days |
| 2023 | 1073 days | $241.21 Million | $224.77K/day | $- | $201.16 Million | ▼ -1274 days |
| 2022 | 2347 days | $299.73 Million | $127.70K/day | $- | $284.42 Million | ▲ +1384 days |
| 2021 | 964 days | $45.93 Million | $47.66K/day | $- | $45.93 Million | ▲ +964 days |
| 2020 | 0 days | $0.00 | $20.07K/day | $- | $0.00 | — |